Events

08 May 2022

Anticipated PhD thesis defense date of the superb clinician-scientist Juliette Pouw: September 1 2022!

Sept 1 2022 at 16:15 hr: PhD thesis defense Juliette Pouw, Utrecht University Academy Building 

1st promotor Marianne Boes, 2nd promotor Jaap van Laar, co-promotoren Emmerik Leijten, Julia Spierings

Read more
06 Dec 2021

PhD thesis defense of the fabulous Sarah Schep! Dec 23 2021

Inhibitors and Immune Tolerance Induction in Hemophilia A: A balancing act Remmers en Immuun Tolerantie Inductie in Hemofilie A: Een delicate balans (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. H.R.B.M. Kummeling, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op donderdag 23 december 2021 des middags te 2.15 uur door Sarah Judith Schep geboren op 10 april 1987 te Gorinchem. Promotoren: Prof. dr. R.E.G. Schutgens Prof. dr. J.J. Voorberg Copromotoren: Dr. M.L. Boes Dr. K. Fischer

Read more
25 Nov 2021

PhD thesis defense of the fabulous Nila Servaas! November 25 2021

Unveiling the two faces of immune dysregulation in Systemic Sclerosis A multi-omics approach Onthulling van de twee gezichten van immuunontregeling bij Systemische Sclerose Een multi-omics benadering (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. H.R.B.M. Kummeling, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op donderdag 25 november 2021 des middags te 4.15 uur door Nila Hendrika Servaas geboren op 30 juni 1993 te Gouda

Read more
10 Nov 2021

PhD defense of the wonderful and talented Emmerik Leijten on June 29 2021!

Psoriasis and PsA have predominantly shared genetic background and overlapping immunologic signature, confirming their denomination as falling within a spectrum of one single disease. Local tissue factors induce a primary inflammatory response, followed by a persistent inflammatory environment that hosts innate and adaptive immune cells with overlapping functional effects. The local inflammatory process of the tissue is capable of determining the phenotype, where psoriasis and/or arthritis can occur in an independent fashion both from clinical and pathophysiological point of view. In the circulating compartment we detected only subtle changes between patients with psoriasis compared to PsA. Main phenotypic manifestations should drive study participant selection for both clinical and basic research questions, without the need to dichotomize PsA versus psoriasis. Promotors: prof. dr. Timothy Radstake and dr. Marianne Boes, UMC Utrecht. 

Read more
16 May 2021

new paper published on immunometabolism in chronic inflammatory disease, by Francesca Ververs et al!

Invariant Natural Killer T (iNKT) cells respond to the ligation of lipid antigen-CD1d complexes via their T-cell receptor and are implicated in various immunometabolic diseases. We considered that immunometabolic factors might affect iNKT cell function. To this end, we investigated iNKT cell phenotype and function in a cohort of adolescents with chronic disease and immunometabolic abnormalities. We analyzed peripheral blood iNKT cells of adolescents with cystic fibrosis (CF, n = 24), corrected coarctation of the aorta (CoA, n = 25), juvenile idiopathic arthritis (JIA, n = 20), obesity (OB, n = 20), and corrected atrial septal defect (ASD, n = 25) as controls. 

Read more
16 May 2021

pubquiz Spring 2021

The team showed its random knowledge, reaching far beyond the life sciences.



Read more
07 Apr 2021

Young Academy events

We presented to Dutch minister of Education, Culture and Science Van Engelshoven, the Alliance proposal of the working group young Academies of TU/e, WUR, UU and UMCU! 

Read more
26 Mar 2021

Lymph&Co

We work together with the Lymph&Co foundation. Lymph&Co draws attention to lymphoid cancer and finances groundbreaking scientific research into better and more effective treatment options.

Read more
This project is funded by
Grant no. 23984234
EU

Share project / Contact us